News
Buprenorphine may curb opioid-induced respiratory depression
“I think this is an approach that works, and this study makes that clear,” said Dr. Geert Jan Groeneveld.
News
FDA OKs stimulation device for anxiety in depression
The neurostimulation system has previously received FDA approval for refractory depression, obsessive-compulsive disorder, and smoking addiction...
News
Pfizer recalls four more lots of smoking cessation drug Chantix
On July 2, the FDA reported that Pfizer had voluntarily recalled nine lots of the drug.
News
FDA head calls for investigation into agency’s approval of aducanumab (Aduhelm)
An independent investigation will examine whether anything occurred that was “inconsistent with FDA policies and procedures.”
News
FDA leader explains rationale leading to controversial Alzheimer’s drug approval
In view of the “fierce public debate” that erupted immediately following the drug’s approval, the FDA felt compelled to explain how it reached its...
News
FDA approves controversial Alzheimer’s drug aducanumab (Aduhelm)
Approval was granted despite an FDA advisory panel recommendation not to approve the drug.
News
Once-nightly sodium oxybate agent effective in narcolepsy
All three doses of the novel agent were associated with significant improvements in sleep quality, refreshing nature of sleep, sleep paralysis,...
News
COVID-19 linked to novel epileptic seizures
Among patients with new-onset seizures, hospital stays were about 15 days longer – and mortality rates were significantly higher.
News
Common MS treatment wears off more quickly in Black patients
These findings may have implications for the way Black patients with autoimmune diseases are treated in the future.
News
Simple blood test plus AI may flag early-stage Alzheimer’s disease
Deep Learning’s assessment of intragenic cytosine-phosphate-guanines (CpGs) had sensitivity and specificity rates of 97%.
News
Borderline personality disorder diagnosis: To tell or not to tell patients?
Not disclosing a diagnosis "is like you're not trusting a patient to be a reasonable adult human about this," said Dr. Amy Barnhorst.
News
Novel Alzheimer’s drug slows cognitive decline in phase 2 trial
The Alzheimer’s Association is encouraged by the promising data, according to Maria Carrillo, PhD, chief science officer for the organization.
News
Meghan Markle interview resurfaces suicidality screening debate
Ask open-ended questions of those patients who are struggling, said Dr. Mona Masood.
News
PTSD prevalent in survivors of severe COVID-19
The results are “in line” with findings reported in other events, such as Hurricane Katrina of 2005, and the 2011 Japan earthquake and tsunami.